首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1541018

2024-2032 年按类型、应用、最终用途和地区分類的神经生物标记市场报告

Neurological Biomarkers Market Report by Type, Application, End Use, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

IMARC Group年，全球神经生物标记市场规模达89亿美元。

神经生物标记是存在于血液或脑脊髓液 (CSF) 中的分子，可支持脑部疾病的诊断和监测疾病进展。这些生物标记的主要来源是基因突变、代谢物水平、脑部影像以及蛋白质表现或翻译后修饰的变化。由于神经生物标记检测对实验药物的生物反应并有助于发现治疗干预的新靶点，因此神经生物标记在药物开发过程中广泛应用于临床实践。目前，研究人员测量生物标记浓度，以提供非侵入性检测、早期诊断和个人化治疗。

中风、运动神经元疾病(MND)、阿兹海默症(AD)、帕金森氏症(PD) 和亨丁顿舞蹈症(HD) 等神经系统疾病的发生率不断上升，对更快药物开发的需求不断增加。这是推动市场成长的主要因素之一，因为生物标记有助于衡量新药和治疗策略的功效。微创手术和个人化药物的日益普及是另一个主要的成长诱导因素。除此之外，由于各种神经系统疾病具有共同的标准特征，因此对多种生物标记来区分特定疾病及其亚型的需求不断增加。此外，质谱和成像程序的进步使得能够更快地评估大量生化标记物和大脑结构变化。随着数位生物标记物的引入和临床试验数量的增加，预计将推动未来几年市场的成长。

本报告回答的关键问题：

迄今为止，全球神经生物标记市场表现如何，未来几年将如何表现？
COVID-19 对全球神经生物标记市场有何影响？
主要区域市场有哪些？
依类型划分市场是怎么样的？
基于应用的市场区隔是什么？
根据最终用途分類的市场是怎样的？
产业价值链的各个阶段是什么？
该行业的关键驱动因素和挑战是什么？
全球神经生物标记市场的结构如何？
产业竞争程度如何？

北美洲
- 美国
- 加拿大
亚太
- 中国
- 日本
- 印度
- 韩国
- 澳洲
- 印尼
- 其他的
欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 俄罗斯
- 其他的
拉丁美洲
- 巴西
- 墨西哥
- 其他的
中东和非洲
- 市场趋势
- 市场细分：按国家/地区
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Abbott Laboratories
- Acumen Pharmaceuticals Inc.
- Athena Diagnostics (Quest Diagnostics)
- Banyan Biomarkers Inc.
- Bio-Rad Laboratories Inc.
- Immunarray Pvt. Ltd.
- Myriad Rbm Inc. (Myriad Genetics Inc.)
- Proteome Sciences Plc
- Thermo Fisher Scientific Inc.

简介目录图表

Product Code: SR112024A3181

The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a growth rate (CAGR) of 11.3% during 2024-2032.

Neurological biomarkers are molecules present in the blood or cerebral spinal fluid (CSF) that support the diagnosis of brain disorders and monitor disease progression. The main sources of these biomarkers are genetic mutations, metabolite levels, brain imaging and changes in protein expression or post-translational modifications. As they detect biological responses to experimental drugs and aid in discovering new targets for therapeutic intervention, neurological biomarkers are widely used in clinical practice during drug development. Presently, researchers measure biomarker concentrations to provide non-invasive testing, earlier diagnosis and personalized treatments.

The rising occurrence of neurological disorders, such as stroke, motor neuron disease (MND), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD), is escalating the need for faster drug development. This represents one of the primary factors impelling the market growth as biomarkers help measure the efficacy of new drugs and therapeutic strategies. The increasing adoption of minimally invasive procedures and personalized medicines are acting as another major growth-inducing factor. Apart from this, as various neurological disorders share standard features, there is an increase in the demand for multiple biomarkers to differentiate specific diseases and their sub-types. Moreover, advancements in mass spectrometry and imaging procedures enable faster evaluation of large numbers of biochemical markers and structural changes in the brain. This, along with the introduction of digital biomarkers and the rising number of clinical trials, is anticipated to propel the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurological biomarkers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end use.

Breakup by Type:

Genomic Biomarkers

Proteomic Biomarkers

Metabolomic Biomarkers

Imaging Biomarkers

Others

Breakup by Application:

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Autism Spectrum Disorders

Others

Breakup by End Use:

Hospital Laboratories

Clinical Diagnostic Centers

Research Organizations

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Acumen Pharmaceuticals Inc., Athena Diagnostics (Quest Diagnostics), Banyan Biomarkers Inc., Bio-Rad Laboratories Inc., Immunarray Pvt. Ltd., Myriad Rbm Inc. (Myriad Genetics Inc.), Proteome Sciences Plc and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global neurological biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neurological biomarkers market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurological biomarkers market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurological Biomarkers Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Genomic Biomarkers
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Proteomic Biomarkers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Metabolomic Biomarkers
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Imaging Biomarkers
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Alzheimer's Disease
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Parkinson's Disease
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Multiple Sclerosis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Autism Spectrum Disorders
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End Use

8.1 Hospital Laboratories
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Clinical Diagnostic Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Research Organizations
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Acumen Pharmaceuticals Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Athena Diagnostics (Quest Diagnostics)
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Banyan Biomarkers Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Bio-Rad Laboratories Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Immunarray Pvt. Ltd.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Myriad Rbm Inc. (Myriad Genetics Inc.)
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Proteome Sciences Plc
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Thermo Fisher Scientific Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Neurological Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Neurological Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Neurological Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Neurological Biomarkers Market: Breakup by Type (in %), 2023
Figure 5: Global: Neurological Biomarkers Market: Breakup by Application (in %), 2023
Figure 6: Global: Neurological Biomarkers Market: Breakup by End Use (in %), 2023
Figure 7: Global: Neurological Biomarkers Market: Breakup by Region (in %), 2023
Figure 8: Global: Neurological Biomarkers (Genomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Neurological Biomarkers (Genomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Neurological Biomarkers (Proteomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Neurological Biomarkers (Proteomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Neurological Biomarkers (Imaging Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Neurological Biomarkers (Imaging Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Neurological Biomarkers (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Neurological Biomarkers (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Neurological Biomarkers (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Neurological Biomarkers (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Neurological Biomarkers (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Neurological Biomarkers (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Neurological Biomarkers (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Neurological Biomarkers (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Neurological Biomarkers (Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Neurological Biomarkers (Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: North America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: North America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: United States: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: United States: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Canada: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Canada: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Asia-Pacific: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Asia-Pacific: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: China: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: China: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Japan: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Japan: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: India: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: India: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: South Korea: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: South Korea: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Australia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Australia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Indonesia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Indonesia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Europe: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Europe: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Germany: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Germany: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: France: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: France: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United Kingdom: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: United Kingdom: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Italy: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Italy: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Spain: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Spain: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Russia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Russia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Latin America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Latin America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Brazil: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Brazil: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Mexico: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Mexico: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Middle East and Africa: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Middle East and Africa: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Neurological Biomarkers Market: Breakup by Country (in %), 2023
Figure 85: Global: Neurological Biomarkers Industry: SWOT Analysis
Figure 86: Global: Neurological Biomarkers Industry: Value Chain Analysis
Figure 87: Global: Neurological Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurological Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Neurological Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Neurological Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Neurological Biomarkers Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 5: Global: Neurological Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Neurological Biomarkers Market: Competitive Structure
Table 7: Global: Neurological Biomarkers Market: Key Players

02-2729-4219

+886-2-2729-4219